Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Diffusive removal of uremic toxins via semipermeable membrane describes the principal mechanism of toxin clearance in hemodialysis (and to a lesser extent peritoneal dialysis), whereby small toxic solutes migrate from blood into dialysate across a membrane driven by concentration gradients[2][3]. This process is essential for patients with kidney failure and operates by passive diffusion; effectiveness depends on pore size, flow rates, and membrane composition. While it efficiently removes small molecules, protein-bound toxins are less removed; larger pore or adsorption-enhanced membranes can improve clearance but may risk removal of useful plasma components (e.g., albumin)[1][2]. The phrase does not specify a biological molecule or receptor, but a physical method central to renal replacement therapy.
Diffusion across semipermeable membrane; Convection (sometimes, if combined); Adsorption (sometimes, if combined)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Diffusive removal of uremic toxins via semipermeable membrane.